Novel materials and devices in the transcatheter management of congenital heart diseases--the future comes slowly (part 1)
Copyright © 2016 Elsevier Masson SAS. All rights reserved..
Management of congenital defects of the heart and great vessels constitutes the largest part of paediatric cardiology practice. Most of these defects require interventions, either corrective or palliative, to guarantee patient survival, symptom relief and/or better quality of life. Interventions can be performed either surgically or transcatheter percutaneously. The surgical repairs are invasive, with long-term results often being suboptimal for complex lesions and after the use of grafts, especially in small patients. Nowadays, various transcatheter devices allow much less invasive percutaneous management in some carefully selected patients with congenital heart disease. However, the currently available materials and devices are only suitable for a small proportion of children, while the majority of young patients with cardiac defects still need surgery, as no transcatheter alternatives exist. There are, however, numerous new biomaterials, devices and technologies that have the potential to expand the transcatheter approach to a much broader spectrum of congenital cardiovascular lesions and conditions. In this three-part review, we describe new advances in transcatheter devices and materials, which promise to extend the application of the percutaneous approach to younger and more complex patient groups with congenital heart disease. The first part focuses on new possibilities for the transcatheter treatment of vascular stenoses in growing patients and the closure of intracardiac defects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:109 |
|---|---|
| Enthalten in: |
Archives of cardiovascular diseases - 109(2016), 4 vom: 20. Apr., Seite 278-85 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sizarov, Aleksander [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 23.01.2017 Date Revised 23.01.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.acvd.2015.12.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM257685480 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM257685480 | ||
| 003 | DE-627 | ||
| 005 | 20231224183351.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.acvd.2015.12.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0859.xml |
| 035 | |a (DE-627)NLM257685480 | ||
| 035 | |a (NLM)26898634 | ||
| 035 | |a (PII)S1875-2136(16)30003-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sizarov, Aleksander |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Novel materials and devices in the transcatheter management of congenital heart diseases--the future comes slowly (part 1) |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.01.2017 | ||
| 500 | |a Date Revised 23.01.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Management of congenital defects of the heart and great vessels constitutes the largest part of paediatric cardiology practice. Most of these defects require interventions, either corrective or palliative, to guarantee patient survival, symptom relief and/or better quality of life. Interventions can be performed either surgically or transcatheter percutaneously. The surgical repairs are invasive, with long-term results often being suboptimal for complex lesions and after the use of grafts, especially in small patients. Nowadays, various transcatheter devices allow much less invasive percutaneous management in some carefully selected patients with congenital heart disease. However, the currently available materials and devices are only suitable for a small proportion of children, while the majority of young patients with cardiac defects still need surgery, as no transcatheter alternatives exist. There are, however, numerous new biomaterials, devices and technologies that have the potential to expand the transcatheter approach to a much broader spectrum of congenital cardiovascular lesions and conditions. In this three-part review, we describe new advances in transcatheter devices and materials, which promise to extend the application of the percutaneous approach to younger and more complex patient groups with congenital heart disease. The first part focuses on new possibilities for the transcatheter treatment of vascular stenoses in growing patients and the closure of intracardiac defects | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Bio-ingénierie | |
| 650 | 4 | |a Biodegradable stent | |
| 650 | 4 | |a Bioengineering | |
| 650 | 4 | |a Cathétérisme interventionnel | |
| 650 | 4 | |a Congenital heart diseases | |
| 650 | 4 | |a Dispositifs innovant | |
| 650 | 4 | |a Malformations cardiaques congénitales | |
| 650 | 4 | |a Novel devices | |
| 650 | 4 | |a Stent biodégradable | |
| 650 | 4 | |a Transcatheter interventions | |
| 700 | 1 | |a Boudjemline, Younes |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of cardiovascular diseases |d 2008 |g 109(2016), 4 vom: 20. Apr., Seite 278-85 |w (DE-627)NLM178732060 |x 1875-2128 |7 nnns |
| 773 | 1 | 8 | |g volume:109 |g year:2016 |g number:4 |g day:20 |g month:04 |g pages:278-85 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.acvd.2015.12.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 109 |j 2016 |e 4 |b 20 |c 04 |h 278-85 | ||